Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Farallon Capital Management, L.L.C.
Form 13F · Q2 2026

Farallon Capital Management, L.L.C.

CIK 909661Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$21.7B
Reported book value
89
Positions
12
Quarters on record
Top 50
Positions

Farallon Capital Management, L.L.C. — holdings

Top 50 positions of 89, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc13.6M—$2.5B11.7%
2ELECTRONIC ARTS INC Electronic Arts Inc7.9M+6.0%$1.6B7.5%
3BBIO Bridgebio Pharma Inc10.7M—$800M3.7%
4PTGX Protagonist Therapeutics Inc6.3M—$778M3.6%
5EXEL Exelixis Inc13.5M—$733M3.4%
6LQDA Liquidia Corporation8.4M—$667M3.1%
7AMZN Amazon Com Inc2.6M—$628M2.9%
8LNTH Lantheus Hldgs Inc5.6M—$619M2.9%
9NTRA Natera Inc2.2M—$602M2.8%
10UNH Unitedhealth Group Inc1.3M—$528M2.4%
11TMO Thermo Fisher Scientific Inc1.0M—$526M2.4%
12ROIV Roivant Sciences Ltd14.3M—$506M2.3%
13AON Aon Plc1.4M—$459M2.1%
14BSX Boston Scientific Corp10.5M—$449M2.1%
15AVGO Broadcom Inc1.2M—$435M2.0%
16MSFT Microsoft Corp1.1M—$415M1.9%
17TNGX Tango Therapeutics Inc12.3M—$384M1.8%
18KKR Kkr & Co Inc4.1M—$378M1.7%
19SNPS Synopsys Inc829,600—$370M1.7%
20BEAM Beam Therapeutics Inc10.2M—$351M1.6%
21CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In9.0M—$336M1.6%
22GRAL Grail Inc4.2M—$284M1.3%
23WAB Wabtec894,503—$241M1.1%
24IMVT Immunovant Inc5.8M—$224M1.0%
25TWST Twist Bioscience Corp2.1M—$220M1.0%
26AGIO Agios Pharmaceuticals Inc5.9M—$220M1.0%
27ARMK Aramark3.6M—$206M1.0%
28BIDU Baidu Inc1.2M—$138M0.6%
29NVO Novo-Nordisk A S2.6M—$126M0.6%
30ACHC Acadia Healthcare Company In4.2M—$125M0.6%
31BTSG Brightspring Health Svcs Inc1.7M—$121M0.6%
32AZN Astrazeneca Plc574,000—$109M0.5%
33JNJ Johnson & Johnson408,000—$104M0.5%
34PBLS Parabilis Medicines Inc2.4M—$65M0.3%
35NVS Novartis Ag363,000—$57M0.3%
36GH Guardant Health Inc322,200—$48M0.2%
37AVTX Avalo Therapeutics Inc2.5M—$46M0.2%
38JOYY Joyy Inc699,200—$46M0.2%
39ASMB Assembly Biosciences Inc1.6M—$44M0.2%
40ENTA Enanta Pharmaceuticals Inc2.4M—$35M0.2%
41MAZE Maze Therapeutics Inc1.1M—$33M0.2%
42MRK Merck & Co Inc199,000—$26M0.1%
43WRBY Warby Parker Inc828,000—$25M0.1%
44PERCEPTIVE CAP SOLUTIONS COR Perceptive Cap Solutions Cor2.2M—$24M0.1%
45KLRA Kailera Therapeutics Inc1.1M—$24M0.1%
46RIO TINTO PLC Rio Tinto Plc183,475—$17M0.1%
47AXTA Axalta Coating Sys Ltd478,000—$16M0.1%
48ABVX Abivax Sa122,000—$16M0.1%
49VNET Vnet Group Inc2.0M—$16M0.1%
50NTES Netease Com Inc123,500—$16M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.